Bleichroeder LP’s Cerence CRNC Stock Holding History

Bleichroeder LP’s Portfolio CRNC Stock Details CRNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-23,695	Closed	-$855K	–	101
2022 Q1	$855K	Buy	+23,695	New	+$1.17M	0.15%	53

Other funds holding CRNC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

VVP

Vulcan Value Partners Birmingham, Alabama $3.29B AUM 6.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bleichroeder LP's CRNC Position: Q2 2022 in Review

Bleichroeder LP sold out of Cerence (CRNC) in Q2 2022, closing a stake of 23,695 shares — an estimated $855K sold.

Bleichroeder LP first reported a position in CRNC in Q1 2022 and held it in 1 quarter. The position peaked at $855K in Q1 2022. 269 funds tracked by Wall St. Rank hold CRNC as of Q2 2022.

Bleichroeder LP reported no remaining Cerence position as of Q2 2022 after selling out during the quarter.
Bleichroeder LP sold 23,695 Cerence shares in Q2 2022, an estimated $855K.
Bleichroeder LP first reported a position in Cerence in Q1 2022 and held it in 1 quarter.
Bleichroeder LP's Cerence position peaked at $855K in Q1 2022.
269 funds tracked by Wall St. Rank held Cerence as of Q2 2022.

Based on Bleichroeder LP's 13F filing for Q2 2022, filed 10 Aug 2022.